Celebrated the XIX European Patients’ Rights Day at the EU Parliament

The 2025 edition provides the most comprehensive and up-to-date analysis of the nursing workforce.

Several mucosal vaccines are in development, and consistent methodologies assessing mucosal IgA are crucial for evaluation across clinical trials.

Novel influenza-like virus sequences previously identified in fish and amphibians were found to cluster as a sister clade of influenza B viruses, but have thus far remained uncharacterized.

Frequency, phenotype and T-cell receptor (TCR) composition of influenza-specific CD8+ T-cells directed at the prominent A2/M158 influenza epitope change across the human lifespan.

In an attempt to transform Europe into a stronger global research hub, the European Union and France have unveiled plans to launch a multi-million-euro initiative aimed at making the EU a "magnet" for top international scientists: "Science has no passport

This strategy aims for 95% of individuals infected with HIV to know their status, 95% of those infected to be under effective treatment, and 95% of those receiving treatment to achieve viral suppression.

The pursuit of rigorous medical science is not compatible with capitulation to government demands aimed at weaponising and eroding science.

Highly pathogenic avian influenza (HPAI) viruses cross species barriers and have the potential to cause pandemics.

The VITAL project published an educational platform as well as a toolbox to boost vaccination uptake amongst older people.

As the UK Pandemic Sciences Network conference kicks off in Glasgow, virus expert Prof Emma Thomson says new technologies are boosting science’s ability to fight novel strains of infectious diseases.

The adaptability is a key factor in AIV to infect multiple non-avian species, including humans, companion animals, aquatic mammals, carnivores, and other mammals.

The aim of such an agreement is to enhance global preparedness for future COVID-19-like pandemics and mitigate the risk of similar catastrophic consequences.

Infection of highly pathogenic avian influenza (HPAI) H5N1 clade 2.3.4.4b in dairy cows causes severe mastitis and milk production losses.

On 2 April 2025, the International Health Regulations (IHR) National Focal Point (NFP) for Mexico notified WHO of the country’s first laboratory-confirmed human infection with an avian influenza A(H5N1) virus in the state of Durango.

At the present time, based on available information, FAO-WHO-WOAH assess the global public health risk of influenza A(H5) viruses to be low.

The receptor-binding preference of haemagglutinin of influenza A viruses (IAVs) is a major determinant of host range, and avian viruses preferentially bind α2,3-linked sialic acids, whereas human IAVs recognize α2,6-linked sialic acids.

After more than three years of negotiations, WHO reached a draft agreement for consideration at the upcoming World Health Assembly in May.

Highly pathogenic H5N1 avian influenza viruses started circulating in lactating dairy cattle in the USA at the end of 2023 and these viruses are now rapidly spreading between cows.

The H5N1 avian panzootic has resulted in cross-species transmission to birds and mammals, causing outbreaks in wildlife, poultry, and US dairy cattle with a range of host-dependent pathogenic outcomes.

The US Department of Agriculture (USDA) has given a conditional approval to animal healthcare company Zoetis for an updated vaccine to protect poultry against the H5N1 bird flu strain.

US spending in biomedicine has driven pre-eminence in academia, Nobel prizes, scientific training discovery, translation and healthcare.

Anti-influenza therapeutics remain essential for the control of influenza infections, which may require hospitalization for the most severe cases.

The spillover of highly pathogenic avian influenza (HPAI) H5N1 virus to dairy cows and shedding of high amounts of infectious virus in milk raised public health concerns.